Search Results

There are 5838 results for: content related to: Experimental therapeutics for patients with myeloproliferative neoplasias

  1. You have free access to this content
    JAK2V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events

    American Journal of Hematology

    Volume 89, Issue 5, May 2014, Pages: 517–523, Alberto Alvarez-Larrán, Beatriz Bellosillo, Arturo Pereira, Ana Kerguelen, Juan Carlos Hernández-Boluda, Luz Martínez-Avilés, Concepción Fernández-Rodríguez, Montse Gómez, Luis Lombardía, Anna Angona, Águeda Ancochea, Alicia Senín, Raquel Longarón, Blanca Navarro, María Collado and Carlos Besses

    Version of Record online : 21 FEB 2014, DOI: 10.1002/ajh.23676

  2. Somatic Mutations in Polycythaemia Vera and Other Philadelphia Chromosome Negative Myeloproliferative Neoplasms

    Standard Article

    eLS

    Lukasz P Gondek and Jerry L Spivak

    Published Online : 17 DEC 2012, DOI: 10.1002/9780470015902.a0024249

  3. You have free access to this content
    The JAK2V617F mutation and thrombosis

    British Journal of Haematology

    Volume 143, Issue 3, November 2008, Pages: 307–320, S. K. Austin and J. R. Lambert

    Version of Record online : 30 MAY 2008, DOI: 10.1111/j.1365-2141.2008.07258.x

  4. You have full text access to this Open Access content
    Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1

    Journal of Cellular and Molecular Medicine

    Volume 13, Issue 2, February 2009, Pages: 215–237, Ayalew Tefferi

    Version of Record online : 23 OCT 2008, DOI: 10.1111/j.1582-4934.2008.00559.x

  5. You have free access to this content
    Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm

    British Journal of Haematology

    Ricardo Helman, Welbert de O. Pereira, Luciana C. Marti, Paulo V. Campregher, Renato Davi Puga, Nelson Hamerschlak, Carlos S. Chiattone and Fabio Pires de S. Santos

    Version of Record online : 21 SEP 2016, DOI: 10.1111/bjh.14327

  6. You have free access to this content
    JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation

    British Journal of Haematology

    Volume 150, Issue 3, August 2010, Pages: 334–344, Seido Oku, Katsuto Takenaka, Takuro Kuriyama, Kotaro Shide, Takashi Kumano, Yoshikane Kikushige, Shingo Urata, Takuji Yamauchi, Chika Iwamoto, Haruko K. Shimoda, Toshihiro Miyamoto, Koji Nagafuji, Junji Kishimoto, Kazuya Shimoda and Koichi Akashi

    Version of Record online : 10 JUN 2010, DOI: 10.1111/j.1365-2141.2010.08249.x

  7. You have free access to this content
    Spleen deflation and beyond: The pros and cons of Janus kinase 2 inhibitor therapy for patients with myeloproliferative neoplasms

    Cancer

    Volume 118, Issue 4, 15 February 2012, Pages: 870–877, Alfonso Quintás-Cardama and Srdan Verstovsek

    Version of Record online : 15 JUL 2011, DOI: 10.1002/cncr.26359

  8. You have full text access to this Open Access content
    The JAK kinase inhibitor CP-690,550 supresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation

    Cancer Science

    Volume 99, Issue 6, June 2008, Pages: 1265–1273, Taghi Manshouri, Alfonso Quintás-Cardama, Roberto H. Nussenzveig, Amos Gaikwad, Zeev Estrov, Josef Prchal, Jorge E. Cortes, Hagop M. Kantarjian and Srdan Verstovsek

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1349-7006.2008.00817.x

  9. You have full text access to this OnlineOpen article
    JAK2 inhibition has different therapeutic effects according to myeloproliferative neoplasm development in mice

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 11, November 2015, Pages: 2564–2574, Franck Debeurme, Catherine Lacout, Claudine Moratal, Rebecca G. Bagley, William Vainchenker, Francisco Adrian and Jean-Luc Villeval

    Version of Record online : 14 JUL 2015, DOI: 10.1111/jcmm.12608

  10. Hematopoietic clonal dominance, stem cell mutations, and evolutionary pattern of JAK2V617F allele burden in polycythemia vera

    European Journal of Haematology

    Volume 94, Issue 3, March 2015, Pages: 251–257, Anna Angona, Alberto Alvarez-Larrán, Beatriz Bellosillo, Luz Martínez-Avilés, Laura Camacho, Concepción Fernández-Rodríguez, Silvia Pairet, Raquel Longarón, Águeda Ancochea, Alicia Senín, Lourdes Florensa and Carles Besses

    Version of Record online : 13 SEP 2014, DOI: 10.1111/ejh.12425

  11. You have free access to this content
    JAK2 and genomic instability in the myeloproliferative neoplasms: A case of the chicken or the egg?

    American Journal of Hematology

    Volume 87, Issue 11, November 2012, Pages: 1028–1036, Linda M. Scott and Vivienne I. Rebel

    Version of Record online : 28 MAY 2012, DOI: 10.1002/ajh.23243

  12. You have free access to this content
    The role of serum erythropoietin level and jak2 v617f allele burden in the diagnosis of polycythaemia vera

    British Journal of Haematology

    Volume 167, Issue 3, November 2014, Pages: 411–417, Àgueda Ancochea, Alberto Álvarez-Larrán, Cristian Morales-Indiano, Francesc García-Pallarols, Luz Martínez-Avilés, Anna Angona, Alicia Senín, Beatriz Bellosillo and Carles Besses

    Version of Record online : 18 JUL 2014, DOI: 10.1111/bjh.13047

  13. You have free access to this content
    Splanchnic vein thrombosis in myeloproliferative neoplasms

    British Journal of Haematology

    Volume 162, Issue 6, September 2013, Pages: 730–747, Mallika Sekhar, Kathryn McVinnie and Andrew K. Burroughs

    Version of Record online : 15 JUL 2013, DOI: 10.1111/bjh.12461

  14. You have full text access to this OnlineOpen article
    Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms

    Journal of Cellular and Molecular Medicine

    Volume 17, Issue 11, November 2013, Pages: 1385–1396, Niccolò Bartalucci, Lorenzo Tozzi, Costanza Bogani, Serena Martinelli, Giada Rotunno, Jean-Luc Villeval and Alessandro M. Vannucchi

    Version of Record online : 17 NOV 2013, DOI: 10.1111/jcmm.12162

  15. You have free access to this content
    Molecular diagnostics of myeloproliferative neoplasms

    European Journal of Haematology

    Volume 95, Issue 4, October 2015, Pages: 270–279, Stephen E. Langabeer, Hajnalka Andrikovics, Julia Asp, Beatriz Bellosillo, Serge Carillo, Karl Haslam, Lasse Kjaer, Eric Lippert, Olivier Mansier, Elisabeth Oppliger Leibundgut, Melanie J. Percy, Naomi Porret, Lars Palmqvist, Jiri Schwarz, Mary F. McMullin, Susanne Schnittger, Niels Pallisgaard, Sylvie Hermouet and on behalf of the MPN&MPNr-EuroNet

    Version of Record online : 18 MAY 2015, DOI: 10.1111/ejh.12578

  16. You have free access to this content
    The JAK2 exon 12 mutations: A comprehensive review

    American Journal of Hematology

    Volume 86, Issue 8, August 2011, Pages: 668–676, Linda M. Scott

    Version of Record online : 14 JUN 2011, DOI: 10.1002/ajh.22063

  17. You have free access to this content
    Clinical correlates of JAK2V617F allele burden in essential thrombocythemia

    Cancer

    Volume 109, Issue 11, 1 June 2007, Pages: 2279–2284, Jaya Kittur, Ryan A. Knudson, Terra L. Lasho, Christy M. Finke, Naseema Gangat, Alexandra P. Wolanskyj, Chin-Yang Li, Wenting Wu, Rhett P. Ketterling, Animesh Pardanani and Ayalew Tefferi

    Version of Record online : 17 APR 2007, DOI: 10.1002/cncr.22663

  18. You have free access to this content
    Differential Sensitivity to JAK Inhibitory Drugs by Isogenic Human Erythroblasts and Hematopoietic Progenitors Generated from Patient-Specific Induced Pluripotent Stem Cells

    STEM CELLS

    Volume 32, Issue 1, January 2014, Pages: 269–278, Zhaohui Ye, Cyndi F. Liu, Lucie Lanikova, Sarah N. Dowey, Chaoxia He, Xiaosong Huang, Robert A. Brodsky, Jerry L. Spivak, Josef T. Prchal and Linzhao Cheng

    Version of Record online : 3 JAN 2014, DOI: 10.1002/stem.1545

  19. You have free access to this content
    The JAK2V617F tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

    British Journal of Haematology

    Volume 131, Issue 3, November 2005, Pages: 320–328, Ayalew Tefferi, Terra L. Lasho, Susan M. Schwager, David P. Steensma, Ruben A. Mesa, Chin-Yang Li, Martha Wadleigh and D. Gary Gilliland

    Version of Record online : 26 SEP 2005, DOI: 10.1111/j.1365-2141.2005.05776.x

  20. You have free access to this content
    Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations

    British Journal of Haematology

    Volume 160, Issue 1, January 2013, Pages: 25–34, Anthony J. Bench, Helen E. White, Letizia Foroni, Anna L. Godfrey, Gareth Gerrard, Susanna Akiki, Abida Awan, Ian Carter, Andrea Goday-Fernandez, Stephen E. Langabeer, Tim Clench, Jordan Clark, Paul A. Evans, David Grimwade, Anna Schuh, Mary F. McMullin, Anthony R. Green, Claire N. Harrison and Nicholas C. P. Cross

    Version of Record online : 11 OCT 2012, DOI: 10.1111/bjh.12075